The Vest Prevention of Early Sudden Death Trial (VEST) PREDiction of ICD Therapies (PREDICTS)

ID Number 08-1226

Principal Investigator(s)
Nicholas T Skipitaris

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


Patients with decreased heart function after a heart attack are at some risk for abnormal heart beats that can result in death. At the present time, it is not possible to tell exactly who will have such problems and how this can be prevented. The purpose of this study is to determine if an FDA approved device called the LifeVest (a wearable automatic defibrillator) worn for the first 60-90 days after a heart attack in patients with decreased heart function will prevent them from dying as a result of the abnormal heart beats and secondly, what tests normally performed in heart attack patients are best in predicting which patients are at risk for abnormal heart beats in years following the heart attack. All devices in this study are already approved by the FDA for use with people who are suffering from this heart condition. Identifier: NCT00628966

Contact Information
Kris Grajny
(212) 241-4313

Recruiting Patients: Yes